Last updated: May 16, 2023
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Treatment
Closure Strategy with figure-of-8
Closure Strategy with Perclose-Proglide system
Clinical Study ID
NCT05859503
PERCLOSE PROGLIDE
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Patients will meet all inclusion criteria:
- Adult patients aged > 18 years
- Patients who have undergone percutaneous interventional procedures
- Patients in whom the procedures have been performed with femoral venous access
- Patients who have required large caliber pods ≥ 14 French.
Exclusion
Exclusion Criteria: Patients must not meet any exclusion criteria:
- Patients who have required access with surgical exposure.
- Patients who have required ipsilateral arterial access with a large caliber ≥ 14French
- Patients with previous vascular surgery.
Study Design
Total Participants: 200
Treatment Group(s): 2
Primary Treatment: Closure Strategy with figure-of-8
Phase:
Study Start date:
May 16, 2023
Estimated Completion Date:
September 01, 2023
Study Description
Connect with a study center
Hospital Universitari Vall D'Hebron
Barcelona, 08035
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.